Feedback / Questions
MNV-201 - Minovia Therapeutics
https://www.globenewswire.com/news-release/2025/04/03/3055005/0/en/Minovia-Therapeutics-Announces-FDA-Clearance-of-Second-IND-Application-for-a-Phase-II-Clinical-Trial-of-Lead-Product-MNV-201-in-Pearson-Syndrome.html
Apr 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next